Format

Send to

Choose Destination
See comment in PubMed Commons below
Eur Respir J Suppl. 2003 Jun;41:29s-35s.

The burden of illness and economic evaluation for COPD.

Author information

  • 1Fred Hutchinson Cancer Research Center, Dept of Pharmacy, University of Washington, Seattle, WA 98109, USA. sramsey@fhcrc.org

Abstract

In today's cost-conscious environment, understanding the economic implications associated with disease processes and their treatments is as important as understanding their clinical impact. Medical expenditures for treating chronic obstructive pulmonary disease (COPD) and the indirect costs of morbidity can represent a substantial economic and social burden. Very little economic information concerning COPD is available, however, particularly outside of a few very well-developed Western nations. This article will provide an approach for conducting high-quality studies aimed at estimating the economic burden of chronic obstructive pulmonary disease and for making economic evaluations of healthcare interventions aimed at preventing and treating this disease.

PMID:
12795329
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk